Immune response to sarcomas. A review.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001580:Benzopyrenes; D001859:Bone Neoplasms / Q000276:immunology; D002273:Carcinogens; D002648:Child; D002675:Child, Preschool; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology; D006084:Graft Rejection; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007273:Injections, Intramuscular; D008214:Lymphocytes / Q000276:immunology; D008748:Methylcholanthrene; D051379:Mice; D008979:Moloney murine leukemia virus; D009365:Neoplasm Regression, Spontaneous; D012516:Osteosarcoma / Q000276:immunology; D012509:Sarcoma / Q000276:immunology* / Q000628:therapy; D012513:Sarcoma, Experimental / Q000209:etiology / Q000276:immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001580:Benzopyrenes; D002273:Carcinogens; D008748:Methylcholanthrene